We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
-4.46%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$10.5B
AUM Growth
+$4.68B
Cap. Flow
+$4.98B
Cap. Flow %
47.59%
Top 10 Hldgs %
29.39%
Holding
7,240
New
774
Increased
2,863
Reduced
2,421
Closed
823

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$413M
2
MSFT icon
Microsoft
MSFT
+$342M
3
AMZN icon
Amazon
AMZN
+$210M
4
TSLA icon
Tesla
TSLA
+$130M
5
NVDA icon
NVIDIA
NVDA
+$126M

Top Sells

Rank Stock Value
1
XLK icon
State Street Technology Select Sector SPDR ETF
XLK
+$51.9M
2
IWM icon
iShares Russell 2000 ETF
IWM
+$45.1M
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$34.7M
4
XLY icon
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
+$27.3M
5
IWB icon
iShares Russell 1000 ETF
IWB
+$11.7M

Sector Composition

Rank Sector Weight
1 Technology 30.51%
2 Consumer Discretionary 11.81%
3 Healthcare 9.9%
4 Communication Services 9.49%
5 Financials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
UNFI icon
3926
United Natural Foods
UNFI
$2.93B
$14K ﹤0.01%
343
-8,648
-96% -$354K
WT icon
3927
WisdomTree
WT
$3.46B
$14K ﹤0.01%
2,418
-1,662
-41% -$9.49K
LENZ
3928
LENZ Therapeutics
LENZ
$149M
$14K ﹤0.01%
397
-455
-53% -$28.5K
JXG
3929
JX Luxventure
JXG
$85.6M
$14K ﹤0.01%
+7
New +$9.32K
SEEL
3930
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
$14K ﹤0.01%
4
-4
-50% -$17.2K
CSSE
3931
DELISTED
Chicken Soup for the Soul Entertainment, Inc. Class A Common Stock
CSSE
$14K ﹤0.01%
1,701
+873
+105% +$9.12K
VIA
3932
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
$14K ﹤0.01%
343
+159
+86% +$8.44K
PGTI
3933
DELISTED
PGT, Inc.
PGTI
$14K ﹤0.01%
782
-10,763
-93% -$218K
AVID
3934
DELISTED
Avid Technology Inc
AVID
$14K ﹤0.01%
406
-4,749
-92% -$147K
LTCH
3935
DELISTED
Latch, Inc. Common Stock
LTCH
$14K ﹤0.01%
3,219
+3,119
+3,119% +$16.3K
DNAD
3936
DELISTED
Social Capital Suvretta Holdings Corp. IV Class A Ordinary Shares
DNAD
$14K ﹤0.01%
1,405
-103
-7% -$1K
SGTX
3937
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$14K ﹤0.01%
721
+436
+153% +$9.71K
AUD
3938
DELISTED
Audacy, Inc.
AUD
$14K ﹤0.01%
4,941
-2,317
-32% -$6.12K
JNCE
3939
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$14K ﹤0.01%
2,082
+133
+7% +$948
DTRTU
3940
DELISTED
DTRT Health Acquisition Corp. Unit
DTRTU
$14K ﹤0.01%
1,386
– –
BSKY
3941
DELISTED
Big Sky Growth Partners, Inc. Class A Common Stock
BSKY
$14K ﹤0.01%
1,404
+294
+26% +$2.85K
HAAC
3942
DELISTED
Health Assurance Acquisition Corp. Class A Common Stock
HAAC
$14K ﹤0.01%
1,497
-4,141
-73% -$40.6K
HIGA
3943
DELISTED
H.I.G. Acquisition Corp.
HIGA
$14K ﹤0.01%
1,385
+557
+67% +$5.47K
RCHG
3944
DELISTED
Recharge Acquisition Corp. Class A Common Stock
RCHG
$14K ﹤0.01%
1,450
+794
+121% +$7.88K
NTUS
3945
DELISTED
Natus Medical Inc
NTUS
$14K ﹤0.01%
532
-1,307
-71% -$31.9K
CHNGU
3946
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
$14K ﹤0.01%
+200
New +$13.5K
NEV
3947
DELISTED
NUVEEN ENHANCED MUNICIPAL VALUE FUND
NEV
$14K ﹤0.01%
+1,042
New +$14.6K
PTE
3948
DELISTED
PolarityTE, Inc. Common Stock
PTE
$14K ﹤0.01%
+2,266
New +$26.2K
EVFM
3949
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
$14K ﹤0.01%
2,834
+394
+16% +$2.48K
EVOL
3950
DELISTED
Evolving Systems, Inc.
EVOL
$14K ﹤0.01%
7,639
+5,390
+240% +$10.4K
156 157
158
159 160

Similar funds

AA
Advisory Alpha Holland, Michigan $4.08B AUM 20.62% 1-Year Est. Return
PL
Plancorp LLC Saint Louis, Missouri $4.1B AUM 25.19% 1-Year Est. Return
DWP
Daymark Wealth Partners Cincinnati, Ohio $4.1B AUM 28.59% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $4.06B AUM 24.91% 1-Year Est. Return
BHC
Bowen Hanes & Co Ponte Vedra Beach, Florida $4.11B AUM 44.45% 1-Year Est. Return
RSWM
Robertson Stephens Wealth Management San Francisco, California $4.06B AUM 32.22% 1-Year Est. Return
DS
DRW Securities Chicago, Illinois $4.11B AUM 21.98% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $4.11B AUM 27.59% 1-Year Est. Return

Tower Research Capital (TRC)'s Q1 2022 Portfolio in Review

As of Q1 2022, Tower Research Capital (TRC) held 7,240 positions worth $10.5B, up 81% from $5.78B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Tower Research Capital (TRC) deployed $4.98B of net new capital in Q1 2022, opening 774 new positions and adding to 2,863 existing holdings. Its largest new stake was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 25% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was iShares Russell 2000 ETF, an estimated $45.1M trimmed.

  • Tower Research Capital (TRC)'s largest Q1 2022 buy was iShares MSCI USA Value Factor ETF: 132,204 shares worth $13.8M.
  • Tower Research Capital (TRC) added most to Apple in Q1 2022, an estimated $413M increase.
  • Tower Research Capital (TRC)'s biggest Q1 2022 reduction was iShares Russell 2000 ETF, cutting an estimated $45.1M.
  • Tower Research Capital (TRC) fully exited State Street Technology Select Sector SPDR ETF in Q1 2022, selling an estimated $51.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 29% of its $10.5B portfolio in Q1 2022.
  • Tower Research Capital (TRC) opened 774 new positions and closed 823 in Q1 2022.
  • Tower Research Capital (TRC)'s portfolio value rose 81% quarter-over-quarter to $10.5B.

Based on Tower Research Capital (TRC)'s 13F filing for Q1 2022, filed 12 May 2022.